BMJ

1. MAHASE E
   Is the flu season starting early-and when should I get vaccinated?
   BMJ. 2026;395:e101110.
   

   >> Share

   
   
2. ZHANG Z, Ploner A, Sengpiel V, Kasheshi N, et al
   Quadrivalent human papillomavirus vaccination before pregnancy and pregnancy outcomes: nationwide, population based case-control study.
   BMJ. 2026;395:e100739.
   

   >> Share

   
   
3. BARANIUK C
   Meningitis B vaccine: Only a quarter of year 13 school leavers in England get jab.
   BMJ. 2026;395:e101035.
   

   >> Share

   
   

   
   Infect Immun

4. DE PASCALIS R, Espich S, Khan H, Toney M, et al
   Erratum for De Pascalis et al., "Transcriptional analyses of peripheral blood lymphocytes obtained shortly after primary immunization discriminate vaccines against Francisella tularensis".
   Infect Immun. 2026 Oct 8:e0051626. doi: 10.1128/iai.00516.
   

   >> Share

   
   
5. MILLER JM, Mara AB, Ozyck RG, Savoie R, et al
   Immune responses induced by a subunit vaccine against Mycoplasma gallisepticum.
   Infect Immun. 2026 Oct 7:e0030526. doi: 10.1128/iai.00305.
   

   >> Share

   
   

   
   J Gen Virol

6. EL-KAFRAWY SA, Putra SS, Abbas AT, Abdel-Dayem UA, et al
   ORF2 of hepatitis E virus: genetic and antigenic variation across genotypes and implications for immunity, diagnostics and vaccine development.
   J Gen Virol. 2026;107:002342.
   

   >> Share

   
   

   
   J Immunol

7. SEGARD A, Goguet E, Haines-Hull H, Williamson KC, et al
   Effects of natural killer cell depletion on innate and adaptive immune responses to COVID mRNA vaccination.
   J Immunol. 2026;215:vkag266.
   

   >> Share

   
   

   
   J Infect Dis

8. CUNNINGHAM CK, Karron RA, McFarland EJ, Giganti MJ, et al
   Evaluation of Three Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/DeltaNS2/Delta1313/I1314L, RSV/6120/DeltaNS2/1030s, and RSV/276 in RSV Seronegative Children.
   J Infect Dis. 2026 Oct 3:jiag489. doi: 10.1093.
   

   >> Share

   
   

   
   J Virol

9. ZHANG Y, Duan Y, Shi L, Zhu X, et al
   A live PRV-vectored bivalent vaccine elicits dual protection against pseudorabies virus and swine acute diarrhea syndrome coronavirus.
   J Virol. 2026 Oct 5:e0119326. doi: 10.1128/jvi.01193.
   

   >> Share

   
   
10. SILVA MARINHO PE, Ghimire D, Tsai Silva J, Devlin J, et al
    Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolates.
    J Virol. 2026 Oct 5:e0122126. doi: 10.1128/jvi.01221.
    

    >> Share

    
    
11. DEL ROSARIO JMM, van Diemen PM, Frost SDW, Vishwanath S, et al
    A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.
    J Virol. 2026 Oct 6:e0107326. doi: 10.1128/jvi.01073.
    

    >> Share

    
    
12. SOUZA CK, Santos JJS, Boggiatto P, Sterle H, et al
    H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves.
    J Virol. 2026 Oct 8:e0128926. doi: 10.1128/jvi.01289.
    

    >> Share

    
    
13. CIACCI ZANELLA G, Vincent ML, Flores L, Aljets EK, et al
    A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine.
    J Virol. 2026 Oct 9:e0084826. doi: 10.1128/jvi.00848.
    

    >> Share

    
    

    
    Nat Med

14. CAZES C, Goni BW, Gabillard D, Owolabi O, et al
    Small quantity lipid-based nutritional supplementation and measles vaccination coverage in children aged 6-23 months: a pragmatic cluster-randomized trial.
    Nat Med. 2026 Oct 2. doi: 10.1038/s41591-026-04675.
    

    >> Share

    
    

    
    PLoS Biol

15. DAILEY KE, Wang Y, Teo QW, Wang C, et al
    Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody.
    PLoS Biol. 2026;24:e3004021.
    

    >> Share

    
    

    
    PLoS One

16. MALKAMU B, Ayalew A, Melake A, Fentie A, et al
    Knowledge, attitudes, and prevention practices regarding human papillomavirus among health and social science female students in Northwest Ethiopia: A comparative cross-sectional study.
    PLoS One. 2026;21:e0359838.
    

    >> Share

    
    
17. KIM Y, Lim MK
    Correction: The potential role of perceived neighborhood social cohesion on COVID-19 vaccination uptake among individuals aged 50 and older: Results from the Korean Community Health Survey.
    PLoS One. 2026;21:e0360162.
    

    >> Share

    
    
18. KANMA-OKAFOR OJ, Ravi P, Ngaybe MGB, Yusoof K, et al
    Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol.
    PLoS One. 2026;21:e0358599.
    

    >> Share

    
    
19. SHARMA J, Mahdeen AA
    An immunoinformatics-driven multiepitope subunit vaccine targeting Oropouche virus: Molecular docking, immune and dynamics simulation approaches.
    PLoS One. 2026;21:e0360186.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

20. MADHUSOODANAN J
    Vaccine data suggest immunity could mitigate dementia. What's the biology behind these apparent effects?
    Proc Natl Acad Sci U S A. 2026;123:e2633554123.
    

    >> Share

    
    

    
    Science

21. HUUS KE, Abo H, Tan YH, Atay E, et al
    The human gut microbiome primes fever after vaccination.
    Science. 2026;394:eaea7733.
    

    >> Share

    
    

    
    Vaccine

22. AIKAWA NE, Medeiros JB, Pasoto SG, Medeiros-Ribeiro AC, et al
    Prospective controlled study of the recombinant zoster vaccine in autoimmune rheumatic disease: robust seroconversion despite intravenous cyclophosphamide.
    Vaccine. 2026;93:129227.
    

    >> Share

    
    
23. DANG HTT, Clark A, Nguyen ALT, Duong HT, et al
    Impact and cost-effectiveness of national implementation of rotavirus vaccination in Vietnam: A modeling study.
    Vaccine. 2026;93:129220.
    

    >> Share

    
    
24. BEOGO I, Kibret TC, Zhang Q, Muray M, et al
    Ethnic disparities in COVID-19 vaccine uptake among among 55+ year-old Canadians: Exploring the role of racial discrimination, chronic disease comorbidities, and conspiracy beliefs.
    Vaccine. 2026;93:129213.
    

    >> Share

    
    
25. GANTER M, Kerstin M, Bottcher J, Donat K, et al
    Reconsidering vaccinate-to-live strategies in EU foot-and-mouth disease control.
    Vaccine. 2026;93:129217.
    

    >> Share

    
    
26. BALDERAS LOAEZA AV, Espinoza Gutierrez BJ, Cruz Mendoza I, Villa Mancera AE, et al
    Assessment of the Fasciola hepatica saposin-like protein 2 (rFhSAP2) vaccine candidate in sheep: Immunogenicity without protective efficacy.
    Vaccine. 2026;93:129223.
    

    >> Share

    
    
27. DICKERSON JC, Adeyemo P, Kim N, Ighodaro E, et al
    Effect of a comic book-based educational intervention on human papillomavirus vaccine knowledge and safety perception among girls aged 9-14 in Nigeria.
    Vaccine. 2026;93:129194.
    

    >> Share

    
    
28. BEOGO I, Xu Y, Kibret TC, Muray M, et al
    Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy.
    Vaccine. 2026;93:129214.
    

    >> Share

    
    
29. BAVDEKAR A, Chansinghakul D, Dhati RM, Zambrano B, et al
    A phase III randomized study: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, and children in India and healthy adolescents and children in South Africa.
    Vaccine. 2026;93:129186.
    

    >> Share

    
    
30. BOSCHIERO MN, Sansone NMS, Marson FAL
    Real-world safety of dengue vaccines in Brazil: A pharmacovigilance study.
    Vaccine. 2026;93:129178.
    

    >> Share

    
    
31. KOPP L, Hofner B, Mentzer D
    Mobile-app-based cohort event monitoring study (CEM) of COVID-19 vaccines.
    Vaccine. 2026;93:129219.
    

    >> Share

    
    
32. JEONG O, Kim PK, Oh H, Lee K, et al
    Sequence-Aware Antigenic Alignment and SRID Potency Interpretation in Influenza Vaccines.
    Vaccine. 2026;93:129191.
    

    >> Share

    
    
33. MAYR W, Knell AI, Boehm AK, Jager M, et al
    Longitudinal SARS-CoV-2 mRNA vaccine immunogenicity in inflammatory bowel disease in relation to anti-TNF therapy and age: a prospective cohort study.
    Vaccine. 2026;94:129224.
    

    >> Share

    
    
34. KUNKEAW N, Nguitragool W, Thosapornvichai T, Buasri N, et al
    Circular RNA vaccines encoding Pvs25 induce antibodies that block Plasmodium vivax transmission.
    Vaccine. 2026;94:129221.
    

    >> Share

    
    
35. MALIBWA D, Lees S, Ewing V, Deogratias D, et al
    Influence of COVID-19 and COVID-19 rumours on trust and uptake of single-dose male HPV vaccination in the Add-Vacc cluster-randomised trial, northwest Tanzania.
    Vaccine. 2026;94:129231.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share